As the market continues its ebb and flow, investors are becoming increasingly discerning, shifting their focus from high-flying stocks to value-driven opportunities. Among the sectors facing scrutiny is the industrial realm, where several stocks have inflated to unsustainable levels. In particular, three industrial stocks stand out as prime candidates for divestment by the end of this month.
Riding the Rails: Wabtec Corp. (WAB)
Known for its ingenious rail solutions, Wabtec Corp. (NYSE:WAB), formerly Westinghouse Air Brake Technologies Corporation, has surged in recent times, riding the wave of rail transport efficiency. Wabtec’s prowess in safety systems such as Positive Train Control has cemented its position as an industry leader. Over the past decade, the company has enjoyed solid growth in both sales and earnings per share (EPS), with respective compound annual growth rates (CAGR) of 17.3% and 8.2%.
However, despite its bright prospects in an evolving transportation landscape, the stock’s meteoric rise of 49% in the past year raises concerns. Trading at a forward price-to-earnings ratio (P/E) of 22.7, Wabtec’s valuation appears lofty, particularly considering its susceptibility to market cyclicality and interest rate fluctuations. Given this precarious balance, it may be prudent for investors to secure profits and contemplate parting ways with Wabtec at its current valuation.
Unearthing Value: Exponent (EXPO)
Specializing in scientific and engineering consulting, Exponent (NASDAQ:EXPO) excels in providing analytical solutions across a spectrum of industries. The company’s domain expertise has been instrumental in pivotal events such as the investigation of the 2010 Deepwater Horizon oil spill, showcasing its problem-solving prowess.
Despite maintaining a steady compound annual growth rate of 7% in both revenues and EPS over the last decade, Exponent’s stock now finds itself at an overvalued juncture. With a forward price-to-sales ratio (P/S) of 10.5 and a forward P/E of 54.7, the current valuation appears difficult to rationalize given the anticipated growth trajectory. While the company’s track record is admirable, the current valuation provides scant room for safety in an investment context.